Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sorafenib:MCnc:Pt:Ser/Plas:Qn

Known as: Sorafenib:Concentración de masa:Punto temporal:Suero o Plasma:Qn, Sorafénib:Masse/Volume:Ponctuel:Sérum/Plasma:Numérique, Sorafenib:KütlKons:Zml?:Ser/Plaz:Kant 
 
National Institutes of Health

Related topics

Related topics

4 relations
PlasSerumUnit of Mass Concentrationsorafenib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
Objective Sorafenib is a recommended treatment for advanced hepatocellular carcinoma. The study is to evaluate the efficacy of… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2014
Highly Cited
2014
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
Exchange of extracellular cystine for intracellular glutamate by the antiporter system xc− is implicated in numerous pathologies… Expand
Review
2013
Review
2013
Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain
Objective: To examine real-world safety and treatment patterns of angiogenesis inhibitors for advanced renal cell carcinoma (aRCC… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE